HomeClinical TopicsFDA approves new drug for PAH

FDA approves new drug for PAH

On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content